In the Italian healthcare system,genetic tests for factor V Leiden and factorII are routinely prescribed to assess the predisposition to venousthromboembolism(VTE)of women who request oral contraception.With specific reference to two subpopulations of women already at risk the study aimed to assess whether current screening practices in Italy are cost-effective.
Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian HealthCare System
COMPAGNI, AMELIA;MELEGARO, ALESSIA;TARRICONE, ROSANNA
2013
Abstract
In the Italian healthcare system,genetic tests for factor V Leiden and factorII are routinely prescribed to assess the predisposition to venousthromboembolism(VTE)of women who request oral contraception.With specific reference to two subpopulations of women already at risk the study aimed to assess whether current screening practices in Italy are cost-effective.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
